Long QT SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Long QT Syndrome
Common conditions include: Long QT Syndrome 1, Long QT Syndrome 2, Long QT Syndrome 3, Long QT Syndrome 5
Office
Dan Roden is a Cardiologist practicing medicine in Nashville, Tennessee. Dr. Roden is rated as an Elite provider by MediFind in the treatment of Long QT Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Long QT Syndrome 5, Long QT Syndrome, Jervell Lange-Nielsen Syndrome (JLNS), Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).
Cleveland Clinic Children's Outpatient Center
Peter Aziz is a Pediatrics provider practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 26 years. Dr. Aziz is rated as an Elite provider by MediFind in the treatment of Long QT Syndrome. He is also highly rated in 64 other conditions, according to our data. His clinical expertise encompasses Wolff-Parkinson-White Syndrome, Long QT Syndrome, Double Discordia, Congenital Heart Disease (CHD), and Cardiac Ablation. Dr. Aziz is board certified in American Board Of Internal Medicine, 2019.
Bassett Medical Center
Anthony Nappi is an Interventional Cardiologist practicing medicine in Cooperstown, New York. Dr. Nappi is rated as a Distinguished provider by MediFind in the treatment of Long QT Syndrome. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Familial Ventricular Tachycardia, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).
Summary: An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are identified, also known as cascade screening. Most cascade screening studies conducted to date have been conducted outside the US, and very few studies have used a rigorous approach involving a comparator group or randomized controlled design. ...
Summary: The goal of this clinical trial is to learn whether the study drug THRV-1268 can safely and effectively shorten the QT interval in people diagnosed with Long QT Syndrome Type 2 (LQTS 2). The study will also learn about the safety and tolerability of THRV-1268 at different doses. The main questions this study aims to answer are: Does THRV-1268 reduce the QTc interval (a measure of the heart's elect...
Simon’s Heart is a nonprofit organization dedicated to raising awareness about, and preventing deaths from, conditions that cause sudden cardiac arrest in children.